Literature DB >> 20501458

The relationship between serum uric acid and chronic kidney disease among Appalachian adults.

Loretta Cain1, Anoop Shankar, Alan M Ducatman, Kyle Steenland.   

Abstract

BACKGROUND: Higher serum uric acid (SUA) levels have been shown to be associated with cardiovascular disease. SUA levels are also associated with hypertension, a strong risk factor for chronic kidney disease (CKD). However, it is unclear whether SUA is independently associated with CKD. We examined the hypothesis that higher SUA levels are positively associated with CKD.
METHODS: We analysed data from the C8 Health Study, a population-based study of Appalachian adults aged ≥18 years and free of cardiovascular disease (n = 49,295, 53% women). SUA was examined as gender-specific quartiles. The outcome of interest was CKD (n = 2,980), defined as an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) from serum creatinine.
RESULTS: Overall, we observed a clear positive association between increasing quartiles of SUA and CKD, independent of confounders. Compared with the lowest quartile of SUA (referent), the multivariable odds ratios (95% confidence interval) for quartiles 2-4, respectively, of CKD were 1.53 (1.31, 1.78), 2.16 (1.86 2.50) and 4.67 (4.07, 5.36); P-trend < 0.0001. This observed positive association persisted in separate analysis among men (P-trend < 0.0001) and women (P-trend < 0.0001).
CONCLUSIONS: In conclusion, higher SUA levels are positively associated with CKD, suggesting that at least part of the reported association between SUA and cardiovascular disease may be mediated by CKD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501458      PMCID: PMC2980994          DOI: 10.1093/ndt/gfq262

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  31 in total

1.  High serum uric acid as a novel risk factor for type 2 diabetes.

Authors:  Abbas Dehghan; Mandy van Hoek; Eric J G Sijbrands; Albert Hofman; Jacqueline C M Witteman
Journal:  Diabetes Care       Date:  2007-10-31       Impact factor: 19.112

2.  Risk factors for end-stage renal disease: 25-year follow-up.

Authors:  Chi-yuan Hsu; Carlos Iribarren; Charles E McCulloch; Jeanne Darbinian; Alan S Go
Journal:  Arch Intern Med       Date:  2009-02-23

3.  The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study.

Authors:  A Shankar; R Klein; B E K Klein; F J Nieto
Journal:  J Hum Hypertens       Date:  2006-10-05       Impact factor: 3.012

4.  Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

Authors:  J Fang; M H Alderman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

5.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

6.  Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men.

Authors:  Raquel Villegas; Yong-Bing Xiang; Qiuyin Cai; Sergio Fazio; MacRae Linton; Honglan Li; Tom Elasy; Wei Zheng; Xiao Ou Shu
Journal:  Metab Syndr Relat Disord       Date:  2010-06       Impact factor: 1.894

7.  Multiple organic anion transporters contribute to net renal excretion of uric acid.

Authors:  Satish A Eraly; Volker Vallon; Timo Rieg; Jon A Gangoiti; William R Wikoff; Gary Siuzdak; Bruce A Barshop; Sanjay K Nigam
Journal:  Physiol Genomics       Date:  2008-02-12       Impact factor: 3.107

8.  Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction.

Authors:  S Bo; R Gambino; M Durazzo; F Ghione; G Musso; L Gentile; M Cassader; P Cavallo-Perin; G Pagano
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

9.  Relationship of uric acid with progression of kidney disease.

Authors:  Michel Chonchol; Michael G Shlipak; Ronit Katz; Mark J Sarnak; Anne B Newman; David S Siscovick; Bryan Kestenbaum; Jan Kirk Carney; Linda F Fried
Journal:  Am J Kidney Dis       Date:  2007-08       Impact factor: 8.860

10.  Uric acid and long-term outcomes in CKD.

Authors:  Magdalena Madero; Mark J Sarnak; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Allan J Collins; Andrew S Levey; Vandana Menon
Journal:  Am J Kidney Dis       Date:  2009-03-20       Impact factor: 8.860

View more
  18 in total

1.  Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Authors:  Stacey E Jolly; Mihriye Mete; Hong Wang; Jianhui Zhu; Sven O E Ebbesson; V Saroja Voruganti; Anthony G Comuzzie; Barbara V Howard; Jason G Umans
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-04       Impact factor: 3.738

Review 2.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

3.  Perfluoroalkyl substances are inversely associated with coronary heart disease in adults with diabetes.

Authors:  Kyoko Honda-Kohmo; Robert Hutcheson; Kim E Innes; Baqiyyah N Conway
Journal:  J Diabetes Complications       Date:  2019-02-20       Impact factor: 2.852

Review 4.  Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Authors:  Emanuela Corsini; Robert W Luebke; Dori R Germolec; Jamie C DeWitt
Journal:  Toxicol Lett       Date:  2014-02-03       Impact factor: 4.372

5.  Dynamics of associations between perfluoroalkyl substances and uric acid across the various stages of glomerular function.

Authors:  Ram B Jain; Alan Ducatman
Journal:  Environ Sci Pollut Res Int       Date:  2019-03-07       Impact factor: 4.223

6.  The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.

Authors:  Tongzhang Zheng; Cairong Zhu; Bryan A Bassig; Simin Liu; Stephen Buka; Xichi Zhang; Ashley Truong; Junhi Oh; John Fulton; Min Dai; Ni Li; Kunchong Shi; Zhengmin Qian; Peter Boyle
Journal:  Int J Epidemiol       Date:  2019-12-01       Impact factor: 7.196

7.  Positive association between perfluoroalkyl chemicals and hyperuricemia in children.

Authors:  Sarah Dee Geiger; Jie Xiao; Anoop Shankar
Journal:  Am J Epidemiol       Date:  2013-04-03       Impact factor: 4.897

8.  Perfluoroalkyl chemicals and elevated serum uric acid in US adults.

Authors:  Anoop Shankar; Jie Xiao; Alan Ducatman
Journal:  Clin Epidemiol       Date:  2011-09-30       Impact factor: 4.790

9.  Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: a cross-sectional study.

Authors:  Lian-Xi Li; Ai-Ping Wang; Rong Zhang; Ting-Ting Li; Jun-Wei Wang; Yu-Qian Bao; Wei-Ping Jia
Journal:  Cardiovasc Diabetol       Date:  2015-04-15       Impact factor: 9.951

10.  The Effects of Cardiometabolic Factors on the Association Between Serum Uric Acid and Chronic Kidney Disease in Chinese Middle-Aged and Older Population: A Mediation Analysis.

Authors:  Lu Xu; Hang Sun; Lili Liu; Siyan Zhan; Shengfeng Wang; Xiaozhen Lv; Yongfeng Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.